BiotechTube
Home/Orphagen Pharmaceuticals/Scott Thacher, Ph.D.
ST

Scott Thacher, Ph.D.

Founder and Chief Executive Officer

Orphagen Pharmaceuticals

Therapeutic Areas

OncologyInflammatory Bowel Disease

Orphagen Pharmaceuticals Pipeline

DrugIndicationPhase
Oncology ProgramAdrenal cancer, head & neck and other squamous cancersPreclinical
IBD ProgramUlcerative colitis and Crohn's diseasePreclinical